Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erhardt Schäfer"'
Autor:
Christian Michel, Andreas Burchert, Andreas Hochhaus, Susanne Saussele, Andreas Neubauer, Michael Lauseker, Stefan W. Krause, Hans-Jochem Kolb, Dieter Kurt Hossfeld, Christoph Nerl, Gabriela M. Baerlocher, Dominik Heim, Tim H Brümmendorf, Alice Fabarius, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Maria-Elisabeth Goebeler, Mathias Hänel, Anthony Ho, Jolanta Dengler, Christiane Falge, Robert Möhle, Stephan Kremers, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, Hans-Walter Lindemann, Cornelius F. Waller, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiri Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, Winfried Gassmann, Michael Schenk, Peter Brossart, Thomas Wündisch, Thomas Geer, Stephan Bildat, Erhardt Schäfer, Joerg Hasford, Rüdiger Hehlmann, Markus Pfirrmann
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Standard first-line therapy of chronic myeloid leukemia is treatment with imatinib. In the randomized German Chronic Myeloid Leukemia-Study IV, more potent BCR-ABL inhibition with 800 mg (‘high-dose’) imatinib accelerated achievement of a deep mo
Externí odkaz:
https://doaj.org/article/8f2e3c990dda4c23bf1aba8a1a3b48ba
Autor:
Andreas Engert, Carsten Kobe, Bernd Hertenstein, Bastian von Tresckow, Max S. Topp, Michael Fuchs, Markus Dietlein, Helen Goergen, Andreas Lohri, Volker Diehl, Josee M. Zijlstra, Julia Meissner, Andreas Rosenwald, Julia Thiemer, Georg Kuhnert, Stephanie Sasse, Peter Borchmann, Georg Maschmeyer, Martin Vogelhuber, Ulrich Dührsen, Stefan W. Krause, Richard Greil, Andreas Viardot, Erhardt Schäfer, Martin Soekler, Christian Baues, Hans Theodor Eich, Martin Wilhelm, Ulrich Keller
Publikováno v:
Fuchs, M, Goergen, H, Kobe, C, Kuhnert, G, Lohri, A, Greil, R, Sasse, S, Topp, M S, Schäfer, E, Hertenstein, B, Soekler, M, Vogelhuber, M, Zijlstra, J M, Keller, U B, Krause, S W, Wilhelm, M, Maschmeyer, G, Thiemer, J, Dührsen, U, Meissner, J, Viardot, A, Eich, H, Baues, C, Diehl, V, Rosenwald, A, Von Tresckow, B, Dietlein, M, Borchmann, P & Engert, A 2019, ' Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma : Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group ', Journal of Clinical Oncology, vol. 37, no. 31, pp. 2835-2845 . https://doi.org/10.1200/JCO.19.00964
Journal of Clinical Oncology, 37(31), 2835-2845. American Society of Clinical Oncology
Journal of Clinical Oncology, 37(31), 2835-2845. American Society of Clinical Oncology
PURPOSE Combined-modality treatment (CMT) with 2× ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for patients with early-stage favorable Hodgkin lymphoma (HL). However, the role of radiot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa469fe12172ec2dda9ea09d53492d2
https://research.vumc.nl/en/publications/79c66fe8-a87f-4981-8d5b-ffffc8af5736
https://research.vumc.nl/en/publications/79c66fe8-a87f-4981-8d5b-ffffc8af5736